Teton Advisors, Inc. Paratek Pharmaceuticals, Inc. Transaction History

Teton Advisors, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$1.52 - $2.8 $13,224 - $24,360	-8,700 Reduced 25.82%	25,000 $55,000
Q1 2023 May 12, 2023	SELL	$1.37 - $2.54 $1,096 - $2,032	-800 Reduced 2.32%	33,700 $85,000
Q4 2022 Feb 13, 2023	SELL	$1.67 - $2.51 $15,865 - $23,844	-9,500 Reduced 21.59%	34,500 $64,000
Q4 2021 Feb 11, 2022	BUY	$4.07 - $5.3 $118,030 - $153,700	29,000 Added 193.33%	44,000 $198,000
Q3 2021 Nov 12, 2021	SELL	$4.7 - $7.24 $18,800 - $28,960	-4,000 Reduced 21.05%	15,000 $73,000
Q3 2020 Nov 06, 2020	SELL	$4.19 - $6.69 $16,760 - $26,760	-4,000 Reduced 17.39%	19,000 $103,000
Q2 2020 Aug 13, 2020	SELL	$2.97 - $5.22 $5,940 - $10,440	-2,000 Reduced 8.0%	23,000 $120,000
Q1 2020 May 14, 2020	SELL	$2.67 - $4.97 $5,340 - $9,940	-2,000 Reduced 7.41%	25,000 $79,000
Q4 2019 Feb 14, 2020	SELL	$2.93 - $4.5 $52,740 - $81,000	-18,000 Reduced 40.0%	27,000 $109,000
Q3 2019 Nov 01, 2019	SELL	$3.08 - $5.76 $144,760 - $270,720	-47,000 Reduced 51.09%	45,000 $194,000
Q2 2019 Aug 02, 2019	SELL	$3.47 - $6.32 $62,460 - $113,760	-18,000 Reduced 16.36%	92,000 $367,000
Q1 2019 May 02, 2019	BUY	$5.36 - $7.24 $10,720 - $14,480	2,000 Added 1.85%	110,000 $590,000
Q4 2018 Jan 30, 2019	BUY	$4.8 - $11.6 $403,200 - $974,400	84,000 Added 350.0%	108,000 $554,000
Q2 2018 Aug 10, 2018	BUY	$10.2 - $13.9 $244,799 - $333,600	24,000 New	24,000 $245,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Teton Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Teton Advisors, Inc. with notifications on news.